Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent RE47731 Kinase inhibitors and method of treating cancer with same

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

University Health Network

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

RE477310

Patent Inventor Names

Sze-Wan Li0

Yong Liu0

Bryan T. Forrest0

Heinz W. Pauls0

Louise G. Edwards0

Miklos Feher0

Narendra Kumar B. Patel0

Peter Brent Sampson0

Date of Patent

November 19, 2019

Patent Application Number

159128840

Date Filed

March 6, 2018

Patent Citations

‌

US Patent 10077255 Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

Patent Citations Received

‌

US Patent 11858915 Polo like kinase 4 inhibitors

‌

US Patent 11667627 Salt and crystal forms of PLK-4 inhibitor

Patent Primary Examiner

‌

Alan D Diamond

Patent abstract

The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE47731 Kinase inhibitors and method of treating cancer with same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API